A detailed history of California State Teachers Retirement System transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 134,160 shares of NBIX stock, worth $17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
134,160
Previous 137,805 2.65%
Holding current value
$17 Million
Previous $19 Million 18.59%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$114.58 - $153.15 $417,644 - $558,231
-3,645 Reduced 2.65%
134,160 $15.4 Million
Q2 2024

Aug 14, 2024

SELL
$130.86 - $143.19 $863,676 - $945,054
-6,600 Reduced 4.57%
137,805 $19 Million
Q1 2024

May 15, 2024

SELL
$130.4 - $143.74 $42,510 - $46,859
-326 Reduced 0.23%
144,405 $19.9 Million
Q4 2023

Feb 13, 2024

SELL
$106.07 - $132.76 $97,584 - $122,139
-920 Reduced 0.63%
144,731 $19.1 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $661,712 - $824,149
-7,038 Reduced 4.61%
145,651 $16.4 Million
Q2 2023

Aug 21, 2023

SELL
$89.53 - $104.87 $424,551 - $497,293
-4,742 Reduced 3.01%
152,689 $14.4 Million
Q1 2023

May 09, 2023

SELL
$94.11 - $123.02 $53,925 - $70,490
-573 Reduced 0.36%
157,431 $15.9 Million
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $263,278 - $313,457
2,467 Added 1.59%
158,004 $18.9 Million
Q3 2022

Nov 18, 2022

SELL
$92.03 - $107.81 $146,235 - $171,310
-1,589 Reduced 1.01%
155,537 $16.5 Million
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $72,227 - $95,366
953 Added 0.61%
157,126 $15.3 Million
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $689,361 - $902,117
-9,515 Reduced 5.74%
156,173 $14.6 Million
Q4 2021

Feb 15, 2022

BUY
$79.65 - $106.22 $133,334 - $177,812
1,674 Added 1.02%
165,688 $14.1 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $325,760 - $374,333
-3,780 Reduced 2.25%
164,014 $15.7 Million
Q2 2021

Aug 16, 2021

SELL
$89.43 - $102.27 $657,847 - $752,298
-7,356 Reduced 4.2%
167,794 $16.3 Million
Q1 2021

May 18, 2021

BUY
$87.57 - $119.4 $195,806 - $266,978
2,236 Added 1.29%
175,150 $17 Million
Q4 2020

Feb 16, 2021

BUY
$86.91 - $108.33 $385,185 - $480,118
4,432 Added 2.63%
172,914 $16.6 Million
Q3 2020

Nov 17, 2020

BUY
$96.16 - $135.15 $378,389 - $531,815
3,935 Added 2.39%
168,482 $16.2 Million
Q2 2020

Aug 17, 2020

BUY
$85.09 - $130.36 $663,957 - $1.02 Million
7,803 Added 4.98%
164,547 $20.1 Million
Q1 2020

May 13, 2020

SELL
$75.11 - $113.76 $176,508 - $267,336
-2,350 Reduced 1.48%
156,744 $13.6 Million
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $1.18 Million - $1.61 Million
13,560 Added 9.32%
159,094 $17.1 Million
Q3 2019

Nov 15, 2019

BUY
$83.82 - $101.5 $145,343 - $176,001
1,734 Added 1.21%
145,534 $13.1 Million
Q2 2019

Aug 14, 2019

BUY
$72.24 - $91.27 $97,451 - $123,123
1,349 Added 0.95%
143,800 $12.1 Million
Q1 2019

May 09, 2019

BUY
$69.31 - $91.53 $147,422 - $194,684
2,127 Added 1.52%
142,451 $12.6 Million
Q4 2018

Feb 13, 2019

BUY
$68.32 - $124.36 $216,164 - $393,475
3,164 Added 2.31%
140,324 $10 Million
Q3 2018

Nov 14, 2018

SELL
$98.88 - $125.85 $4,746 - $6,040
-48 Reduced 0.03%
137,160 $16.9 Million
Q2 2018

Aug 14, 2018

BUY
$75.3 - $105.99 $113,477 - $159,726
1,507 Added 1.11%
137,208 $13.5 Million
Q1 2018

May 15, 2018

SELL
$75.88 - $92.43 $217,927 - $265,458
-2,872 Reduced 2.07%
135,701 $11.3 Million
Q4 2017

Feb 14, 2018

SELL
$58.53 - $77.59 $125,078 - $165,809
-2,137 Reduced 1.52%
138,573 $10.8 Million
Q3 2017

Nov 13, 2017

BUY
$47.97 - $61.28 $6.75 Million - $8.62 Million
140,710
140,710 $8.62 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.